Nanotechnology Characterization Tools for Tissue Engineering and Medical Therapy

Dr. Challa S.S.R. Kumar is currently with Harvard University as a Managing Director. He was previously the Director of Nanofabrication and Nanomaterials at the Center for Advanced Microstructures and Devices at Louisiana State University in Baton Rouge, USA. He is also President and CEO of Magnano Technologies and has some years of industrial R&D experience working for Imperial Chemical Industries and United Breweries. His main research interests are the development of novel synthetic methods, including those based on microfluidic reactors, for the synthesis of multifunctional nanomaterials. Dr. Kumar is the winner of the 2006 Nano 50 Technology Award for his work in magnetic-based nanoparticles for cancer imaging and treatment. He is currently the Editor-in-Chief of the international journal “Nanotechnology Reviews”. He has been editor and author of several books and journal articles, and the founding editor of the Journal of Biomedical Nanotechnology.

• Nanotechnology-Based Stem Cell Tissue Engineering with a Focus on Regeneration of Cardiovascular Systems.- Characterization Tools for Mechanical Probing of Biomimetic Materials.- Open-Channel Separation Techniques for the Characterization of Nanomaterials and Their Bioconjugates for Drug Delivery Applications.- Using Integrated Cancer-on-Chip Platforms to Emulate and Probe Various Cancer Models.- Design of Nanoparticles for Focused Ultrasound Drug Delivery.- Magneto-Responsive Nanomaterials for Medical Therapy in Preclinical and Clinical Settings.- Superparamagnetic Nanoparticles for Cancer Hyperthermia Treatment .- Quantitative Methods for Investigating Dissociation of Fluorescently Labeled Lipid from Drug Delivery Liposomes.- Integrated Multilayer Microfluidic Platforms with Silicon Architectures for Next Generation Health Diagnostic Systems.- Characterization of ATP Nanoliposome Treatment for Regeneration of Injured Spinal Cord.- An Insight into Characterizations and Applications ofNanoparticulate Targeted Drug Delivery Systems.